IL138605A - Fizzy formulations - Google Patents

Fizzy formulations

Info

Publication number
IL138605A
IL138605A IL13860599A IL13860599A IL138605A IL 138605 A IL138605 A IL 138605A IL 13860599 A IL13860599 A IL 13860599A IL 13860599 A IL13860599 A IL 13860599A IL 138605 A IL138605 A IL 138605A
Authority
IL
Israel
Prior art keywords
fizzy
formulations
fizzy formulations
Prior art date
Application number
IL13860599A
Other languages
English (en)
Other versions
IL138605A0 (en
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of IL138605A0 publication Critical patent/IL138605A0/xx
Publication of IL138605A publication Critical patent/IL138605A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13860599A 1998-03-31 1999-03-20 Fizzy formulations IL138605A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814257A DE19814257A1 (de) 1998-03-31 1998-03-31 Brauseformulierungen
PCT/DE1999/000798 WO1999049842A1 (de) 1998-03-31 1999-03-20 Brauseformulierungen

Publications (2)

Publication Number Publication Date
IL138605A0 IL138605A0 (en) 2001-10-31
IL138605A true IL138605A (en) 2005-11-20

Family

ID=7863015

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13860599A IL138605A (en) 1998-03-31 1999-03-20 Fizzy formulations

Country Status (28)

Country Link
US (1) US6242002B1 (cs)
EP (1) EP1067905B1 (cs)
JP (1) JP4469494B2 (cs)
KR (1) KR100607395B1 (cs)
CN (1) CN1138529C (cs)
AR (1) AR018829A1 (cs)
AT (1) ATE224703T1 (cs)
AU (1) AU753194B2 (cs)
BG (1) BG65043B1 (cs)
BR (1) BR9909266A (cs)
CA (1) CA2326502C (cs)
CZ (1) CZ300705B6 (cs)
DE (2) DE19814257A1 (cs)
DK (1) DK1067905T3 (cs)
ES (1) ES2183555T3 (cs)
HU (1) HU229793B1 (cs)
IL (1) IL138605A (cs)
NO (1) NO329143B1 (cs)
NZ (1) NZ506989A (cs)
PL (1) PL192049B1 (cs)
PT (1) PT1067905E (cs)
RU (1) RU2221554C2 (cs)
SK (1) SK284477B6 (cs)
TR (1) TR200002812T2 (cs)
TW (1) TW580398B (cs)
UA (1) UA66847C2 (cs)
WO (1) WO1999049842A1 (cs)
ZA (1) ZA200005133B (cs)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
AU2004242477B2 (en) * 1999-03-26 2007-04-19 Cima Labs Inc. Sublingual buccal effervescent
AU2007203233B2 (en) * 1999-03-26 2010-02-25 Cima Labs Inc. Sublingual buccal effervescent
AU6381201A (en) * 2000-03-28 2001-10-08 Biochemie Gmbh Granulated particles with masked taste
JP4706096B2 (ja) * 2000-10-23 2011-06-22 大正製薬株式会社 不快な味を呈する塩基性薬物配合製剤
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
US20040175456A1 (en) * 2003-03-06 2004-09-09 Lauren Keilbach Tablets for feeding fish and methods of making tablets for feeding fish
US20040191298A1 (en) * 2003-03-26 2004-09-30 Fredrik Nicklasson New formulations and use thereof
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
WO2005065317A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
PL1708686T3 (pl) 2003-12-31 2011-08-31 Cima Labs Inc Doustna forma dawkowania fentanylu w postaci musującej o charakterze liniowym oraz sposoby jego podawania
WO2005065318A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral opiate dosage form
US7033511B2 (en) 2004-01-20 2006-04-25 A-Dec, Inc. Sustained water treatment in dental equipment
EP1750677B1 (en) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CN102716490A (zh) * 2005-09-01 2012-10-10 卫材R&D管理有限公司 药物组合物的崩解性的改善方法
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US9757455B2 (en) * 2005-11-28 2017-09-12 Johnson & Johnson Consumer Inc. Oral therapeutic compound delivery system
MX2011003984A (es) * 2008-10-14 2011-05-10 Mcneil Ab Forma de dosis intraoral de multiples porciones y uso de esta.
KR101233352B1 (ko) * 2009-04-22 2013-02-25 (주)비씨월드제약 유전자 재조합 과립구-대식세포 집락 촉진인자를 함유하는 정제
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CA2828946C (en) 2011-04-18 2016-06-21 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
EP3444363B1 (en) 2011-06-03 2020-11-25 Eisai R&D Management Co., Ltd. Biomarkers for prediciting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
MX2014009247A (es) 2012-02-01 2014-10-14 Intercontinental Great Brands Llc Tableta para bebida baja en calorias.
KR20150098605A (ko) 2012-12-21 2015-08-28 에자이 알앤드디 매니지먼트 가부시키가이샤 퀴놀린 유도체의 비정질 형태 및 그의 제조방법
EP2997377B1 (en) 2013-05-14 2018-07-18 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
HUE059606T2 (hu) 2014-08-28 2022-11-28 Eisai R&D Man Co Ltd Nagy tisztaságú kinolinszármazék és eljárás elõállítására
AU2016224583B2 (en) 2015-02-25 2021-06-03 Eisai R&D Management Co., Ltd. Method for suppressing bitterness of quinoline derivative
AU2015384801B2 (en) 2015-03-04 2022-01-06 Eisai R&D Management Co., Ltd. Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
JP6757959B2 (ja) 2015-06-16 2020-09-23 株式会社 PRISM BioLab 抗がん剤
CA2994925C (en) 2015-08-20 2023-08-29 Eisai R&D Management Co., Ltd. Tumor therapeutic agent
BR112019014127A2 (pt) 2017-02-08 2020-02-11 Eisai R&D Management Co., Ltd. Composição farmacêutica para tratamento de tumores
MX2019013014A (es) 2017-05-16 2020-08-06 Eisai R&D Man Co Ltd Tratamiento de carcinoma hepatocelular.
CN109303334B (zh) * 2018-10-17 2021-04-13 汤臣倍健股份有限公司 一种口腔微泡腾片及其制备方法
ES2945809T3 (es) * 2019-10-02 2023-07-07 Intas Pharmaceuticals Ltd Composiciones farmacéuticas sólidas efervescentes prácticamente sin sodio
WO2021239541A1 (en) * 2020-05-28 2021-12-02 Unilever Ip Holdings B.V. Tablet
MX2022015714A (es) 2020-06-08 2023-01-24 Nicoventures Trading Ltd Composicion oral efervescente que comprende un ingrediente activo.

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
US4861800A (en) 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5128145A (en) 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
HU209605B (en) 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
JP3517233B2 (ja) * 1991-07-01 2004-04-12 ゲルゲリイ、ゲルハルト 反応注入した発泡システム
DK0521388T3 (da) 1991-07-01 1995-09-11 Gergely Gerhard Fremgangsmåde til fremstilling af et farmaceutisk præparat med mindst to forskellige aktivstoffer samt anvendelsen af et sådant præparat
EP0593807A1 (en) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
DK0647137T3 (da) 1992-06-22 2008-12-08 State Of Oregon Through Oregon Glycinreceptorantagonister og anvendelse deraf
DE4225730C2 (de) 1992-08-04 2003-04-30 Merz Pharma Gmbh & Co Kgaa Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
CA2153243A1 (en) 1993-01-27 1994-08-18 Harold E. Selick Compositions and methods for transdermal drug delivery
US5287394A (en) 1993-03-22 1994-02-15 Advanced Micro Devices, Inc. Fast counter with uniform delay structures
SE9301112D0 (sv) 1993-04-02 1993-04-02 Orion-Yhtymae Oy A new composition
ATE140621T1 (de) * 1993-04-15 1996-08-15 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen wirkstoff, und verfahren zur herstellung
US5683711A (en) 1993-04-20 1997-11-04 Hexal Pharma Gmbh Active ingredient patch
US5503844A (en) 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
CZ285475B6 (cs) 1993-09-09 1999-08-11 Gerhard Gergely Šumící granulát a způsob jeho výroby
BR9408047A (pt) 1993-11-12 1996-12-24 Gerhard Gergely Processo para produção de granulado
RU2043099C1 (ru) * 1994-01-31 1995-09-10 Анатолий Евгеньевич Добротворский Фармацевтическая композиция в форме шипучих таблеток и способ ее получения
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US5603955A (en) 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
HU223475B1 (hu) 1994-10-24 2004-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
DE29500718U1 (de) * 1995-01-18 1995-04-06 Rau, Reinhard, 37242 Bad Sooden-Allendorf Element einer Zeltplane zum Aufbau von kohten- und jurtenähnlichen Zeltaufbauten
DK0866691T4 (da) 1995-11-06 2005-06-06 Somerset Pharmaceuticals Inc Medikamenter til sublingual og bukkal administration af selegilin

Also Published As

Publication number Publication date
TW580398B (en) 2004-03-21
PL192049B1 (pl) 2006-08-31
CN1295463A (zh) 2001-05-16
ES2183555T3 (es) 2003-03-16
BG104841A (en) 2001-07-31
EP1067905A1 (de) 2001-01-17
DE19814257A1 (de) 1999-10-07
US6242002B1 (en) 2001-06-05
ATE224703T1 (de) 2002-10-15
WO1999049842A1 (de) 1999-10-07
HK1036010A1 (en) 2001-12-21
CN1138529C (zh) 2004-02-18
NZ506989A (en) 2002-09-27
IL138605A0 (en) 2001-10-31
CA2326502A1 (en) 1999-10-07
NO329143B1 (no) 2010-08-30
DK1067905T3 (da) 2003-02-03
BR9909266A (pt) 2000-11-21
CZ20003482A3 (en) 2001-05-16
HUP0101427A3 (en) 2001-12-28
NO20004721D0 (no) 2000-09-21
SK14322000A3 (sk) 2001-07-10
UA66847C2 (uk) 2004-06-15
DE59902843D1 (de) 2002-10-31
JP4469494B2 (ja) 2010-05-26
AU753194B2 (en) 2002-10-10
SK284477B6 (sk) 2005-04-01
NO20004721L (no) 2000-09-21
EP1067905B1 (de) 2002-09-25
CZ300705B6 (cs) 2009-07-22
BG65043B1 (bg) 2007-01-31
RU2221554C2 (ru) 2004-01-20
KR20010042317A (ko) 2001-05-25
PL343260A1 (en) 2001-07-30
ZA200005133B (en) 2001-02-28
AU4029499A (en) 1999-10-18
HU229793B1 (en) 2014-07-28
HUP0101427A2 (hu) 2001-08-28
PT1067905E (pt) 2003-02-28
KR100607395B1 (ko) 2006-08-02
CA2326502C (en) 2008-08-05
TR200002812T2 (tr) 2001-01-22
AR018829A1 (es) 2001-12-12
JP2002509872A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
IL138605A (en) Fizzy formulations
PL343021A1 (en) Formulations
GB9715751D0 (en) Formulations
EP1113799A4 (en) PROTEIN-BASED PREPARATION
PL344327A1 (en) Novel particulate formulations
PL349788A1 (en) Agrochemical formulations
PL346423A1 (en) Microcapsule formulations
PL346414A1 (en) Microcapsule formulations
GB9806312D0 (en) Novel formulations
DE59900495D1 (en) Multimetalloxidmassen
HU9900892D0 (en) Enclosed multiple-biofilter
GB9815002D0 (en) Formulations
GB9810180D0 (en) Novel formulation
DE59900471D1 (en) Inchbremseinrichtung
GB9815001D0 (en) Formulations
GB9810181D0 (en) Novel formulations
GB9816697D0 (en) Liquid formulations
SI1067905T1 (en) Fizzy formulations
TW407677U (en) Form
GB9814483D0 (en) Challenge
GB9818910D0 (en) Novel formulation
GB9818905D0 (en) Novel formulation
GB9823645D0 (en) Formulation
SI1468689T1 (sl) Pripravek 2-metil-tieno-benzodiazepina
GB9704521D0 (en) Formulations

Legal Events

Date Code Title Description
HP Change in proprietorship
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees